Biologics

Biologic allograft products such as blood, bone, skin and tendons have distinct reimbursement challenges, particularly when it comes to coding. Reimbursement Principles has experience with a variety of human and animal grafting products, working through complex coding and coverage problems. We have been highly involved with new HCPCS code applications for biological products, including stem cells, human connective tissue, islet cell transplants, fat grafts for reconstructive surgery and xenograft tissue for heart valve replacement procedures.